US 2014/0350108 A1 · N-Acetyl Beta Alanine Methods of Use

Abstract

Method for preventing paresthesia in a human is disclosed. The method includes administering to the human an effective amount of N-Acetyl Beta Alanine or an N-Acetyl Beta Alanine composition.

Claims1

Dependent claims

A method for preventing paresthesia in a human, the method comprising administering to the human an effective amount of N-Acetyl Beta Alanine.

Dependencies are inferred from the claim text.

Facts

Application

14/456,637Filed 11 Aug 2014

Priority

13 Apr 2011

Published

27 Nov 2014

Term ends

Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 31/198
The amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine,…:…
A61K 31/197
Having an amino group: the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA],…
A61P 3/00
Drugs for disorders of the metabolism
A61P 9/00
Drugs for disorders of the cardiovascular system

Family

Application61/475,179Us provisional application · filed 13 Apr 2011

Application13/446,416Continuation · filed 13 Apr 2012

Application14/456,637Continuation

US 11,534,419 B2Related patent

US 2012/0264826 A1Published application

US 8,802,731 B2Related patent

US 2014/0350108 A1This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Method for preventing paresthesia in a human is disclosed. The method includes administering to the human an effective amount of N-Acetyl Beta Alanine or an N-Acetyl Beta Alanine composition.

N-Acetyl Beta Alanine Methods of Use

Life of this patent

Abstract

Claims1

N-Acetyl Beta Alanine Methods of Use

Life of this patent

Abstract

Claims1